Clinical trial
The Effect Of E2007 On Pharmacodynamic Responses To Levodopa Among Patients With…
NCT00451633 · Eisai Inc., Industry · Withdrawn
Key facts
| NCT number | NCT00451633 |
|---|---|
| Title | The Effect Of E2007 On Pharmacodynamic Responses To Levodopa Among Patients With Parkinson's Disease Who Experience Dyskinesia And Motor Fluctuations |
| Official title | A Randomized, Double Blind, Placebo-Controlled Study To Investigate The Effect Of E2007 On Pharmacodynamic Responses To Levodopa Among Patients With Parkinson's Disease Who Experience Dyskinesia And Motor Fluctuations |
| Lead sponsor | Eisai Inc., Industry |
| Status | Withdrawn |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Parkinson's Disease |
| Intervention type | Drug |
| Interventions | E2007 |
| Enrollment | 0 |
| Start date | Mar 1, 2007 |
| First posted | Mar 23, 2007 |
| Last update posted | Oct 31, 2013 |
| Countries | Germany, Italy |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: